Sanofi-Aventis Business Development Head Hofstaetter To Resign
This article was originally published in The Pink Sheet Daily
Executive Summary
Thomas Hofstaetter was to be one of 10 former Aventis employees to join the merged board's management committee. Sanofi-Aventis says it will still meet its Jan. 1 deadline for having a new operational structure in place.
You may also be interested in...
Former Aventis Exec Hofstaetter Finds A New Home At Wyeth
Thomas Hofstaetter is responsible for business and corporate development as a senior VP, reporting to Wyeth CEO Robert Essner and Pharmaceuticals President Bernard Poussot.
Former Aventis Exec Hofstaetter Finds A New Home At Wyeth
Thomas Hofstaetter is responsible for business and corporate development as a senior VP, reporting to Wyeth CEO Robert Essner and Pharmaceuticals President Bernard Poussot.
Sanofi-Aventis Business Development Head Is Olivier Jacquesson
Jacquesson replaces Thomas Hofstaetter who announced his departure amidst the merger integration. Like Hofstaetter, Jacquesson previously served as an exec at Aventis where he was responsible for marketing activities in France.